IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes

Journal of Immunology

Volumn 181, Issue 12, 2008, Pages 8504-8512

  Peric, Mark ^a   Koglin, Sarah ^a   Kim, Song Min ^a   Morizane, Shin ^b   Besch, Robert ^a   Prinz, Jörg C ^a   Ruzicka, Thomas ^a   Gallo, Richard L ^b   Schauber, Jürgen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BETA DEFENSIN 2; CALCITRIOL; CATHELICIDIN; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN ACT1; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; AUTACOID; CATHELICIDIN ANTIMICROBIAL PEPTIDE; COLECALCIFEROL; IL17A PROTEIN, HUMAN; TRAF3IP2 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; TH17 CELL; BIOSYNTHESIS; CELL LINE; DRUG EFFECT; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; UPREGULATION;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CELL LINE; CELLS, CULTURED; CHOLECALCIFEROL; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-17; KERATINOCYTES; MAP KINASE SIGNALING SYSTEM; PSORIASIS; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; UP-REGULATION;

EID: 58849143880     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.12.8504     Document Type: Article

References (35)

1. Nickoloff, B. J., J. Z. Qin, and F. O. Nestle. 2007. Immunopathogenesis of psoriasis. Clin. Rev. Allergy Immunol. 33: 45-56.
2. Lande, R., J. Gregorio, V. Facchinetti, B. Chatterjee, Y. H. Wang, B. Homey, W. Cao, Y. H. Wang, B. Su, F. O. Nestle, et al. 2007. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449: 564-569. (Pubitemid 47525141)
3. Nestle, F. O., C. Conrad, A. Tun-Kyi, B. Homey, M. Gombert, O. Boyman, G. Burg, Y. J. Liu, and M. Gilliet. 2005. Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J. Exp. Med. 202: 135-143. (Pubitemid 41002916)
4. Schauber, J., and R. L. Gallo. 2008. Antimicrobial peptides and the skin immune defense system. J. Allergy Clin. Immunol. 122: 261-266.
5. Agerberth, B., J. Charo, J. Werr, B. Olsson, F. Idali, L. Lindbom, R. Kiessling, H. Jornvall, H. Wigzell, and G. H. Gudmundsson. 2000. The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96: 3086-3093. (Pubitemid 30815217)
6. Schauber, J., and R. L. Gallo. 2007. Expanding the roles of antimicrobial peptides in skin: alarming and arming keratinocytes. J. Invest. Dermatol. 127: 510-512. (Pubitemid 46271015)
7. Oppenheim, J. J., P. Tewary, G. de la Rosa, and D. Yang. 2007. Alarmins initiate host defense. Adv. Exp. Med. Biol. 601: 185-194.
8. Zaiou, M., and R. L. Gallo. 2002. Cathelicidins, essential gene-encoded mammalian antibiotics. J. Mol. Med. 80: 549-561.
9. Braff, M. H., M. A. Hawkins, A. Di Nardo, B. Lopez-Garcia, M. D. Howell, C. Wong, K. Lin, J. E. Streib, R. Dorschner, D. Y. Leung, and R. L. Gallo. 2005. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities. J. Immunol. 174: 4271-4278.
10. Dorschner, R. A., V. K. Pestonjamasp, S. Tamakuwala, T. Ohtake, J. Rudisill, V. Nizet, B. Agerberth, G. H. Gudmundsson, and R. L. Gallo. 2001. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol. 117: 91-97.
11. Ong, P. Y., T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R. L. Gallo, and D. Y. Leung. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347: 1151-1160.
12. Schauber, J., R. A. Dorschner, K. Yamasaki, B. Brouha, and R. L. Gallo. 2006. Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology 118: 509-519. (Pubitemid 44079569)
13. Wang, T.-T., F. Nestel, V. Bourdeau, Y. Nagai, Q. Wang, J. Liao, L. Tavera-Mendoza, R. Lin, J. H. Hanrahan, S. Mader, and J. H. White. 2004. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173: 2909-2912.
14. Wilson, N. J., K. Boniface, J. R. Chan, B. S. McKenzie, W. M. Blumenschein, J. D. Mattson, B. Basham, K. Smith, T. Chen, F. Morel, et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8: 950-957. (Pubitemid 47300009)
15. Boniface, K., E. Guignouard, N. Pedretti, M. Garcia, A. Delwail, F. X. Bernard, F. Nau, G. Guillet, G. Dagregorio, H. Yssel, et al. 2007. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin. Exp. Immunol. 150: 407-415. (Pubitemid 350098734)
16. Prinz, J. C., B. Gross, S. Vollmer, P. Trommler, I. Strobel, M. Meurer, and G. Plewig. 1994. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur. J. Immunol. 24: 593-598.
17. Schauber, J., R. A. Dorschner, A. B. Coda, A. S. Buchau, P. T. Liu, D. Kiken, Y. R. Helfrich, S. Kang, H. Z. Elalieh, A. Steinmeyer, et al. 2007. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 117: 803-811. (Pubitemid 46348539)
18. Hartupee, J., C. Liu, M. Novotny, X. Li, and T. Hamilton. 2007. IL-17 enhances chemokine gene expression through mRNA stabilization. J. Immunol. 179: 4135-4141.
19. 3. J. Invest. Dermatol. 128: 816-824.
20. Kao, C. Y., F. Huang, Y. Chen, P. Thai, S. Wachi, C. Kim, L. Tam, and R. Wu. 2005. Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-κB-dependent signaling pathway. J. Immunol. 175: 6676-6685.
21. Di Nardo, A., M. H. Braff, K. R. Taylor, C. Na, R. D. Granstein, J. E. McInturff, S. Krutzik, R. L. Modlin, and R. L. Gallo. 2007. Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J. Immunol. 178: 1829-1834. (Pubitemid 46154655)
22. Niyonsaba, F., H. Ushio, I. Nagaoka, K. Okumura, and H. Ogawa. 2005. The human β-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J. Immunol. 175: 1776-1784. (Pubitemid 41023082)
23. Koczulla, R., G. von Degenfeld, C. Kupatt, F. Krötz, S. Zahler, T. Gloe, K. Issbrücker, P. Unterberger, M. Zaiou, C. Lebherz, et al. 2003. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111: 1665-1672. (Pubitemid 38057748)
24. Carretero, M., M. J. Escámez, M. García, B. Duarte, A. Holguín, L. Retamosa, J. L. Jorcano, M. D. Río, and F. Larcher. 2008. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J. Invest. Dermatol. 128: 223-236. (Pubitemid 350249392)
25. Yamasaki, K., A. Di Nardo, A. Bardan, M. Murakami, T. Ohtake, A. Coda, R. A. Dorschner, C. Bonnart, P. Descargues, A. Hovnanian, et al. 2007. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat. Med. 13: 975-980. (Pubitemid 47222043)
26. van Beelen, A. J., M. B. Teunissen, M. L. Kapsenberg, and E. C. de Jong. 2007. Interleukin-17 in inflammatory skin disorders. Curr. Opin. Allergy Clin. Immunol. 7: 374-381.
27. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279.
28. Qian, Y., C. Liu, J. Hartupee, C. Z. Altuntas, M. F. Gulen, D. Jane-Wit, J. Xiao, Y. Lu, N. Giltiay, J. Liu, et al. 2007. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8: 247-256. (Pubitemid 46745374)
29. Schauber, J., K. Iffland, S. Frisch, T. Kudlich, B. Schmausser, M. Eck, T. Menzel, A. Gostner, H. Luhrs, and W. Scheppach. 2004. Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells. Mol. Immunol. 41: 847-854. (Pubitemid 38903168)
30. Schauber, J., C. Svanholm, S. Termen, K. Iffland, T. Menzel, W. Scheppach, R. Melcher, B. Agerberth, H. Luhrs, and G. H. Gudmundsson. 2003. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signaling pathways. Gut 52: 735-741. (Pubitemid 36528878)
31. Kawaguchi, M., F. Kokubu, M. Odaka, S. Watanabe, S. Suzuki, K. Ieki, S. Matsukura, M. Kurokawa, M. Adachi, and S. K. Huang. 2004. Induction of granulocyte-macrophage colony-stimulating factor by a new cytokine, ML-1 (IL- 17F), via Raf I-MEK-ERK pathway. J. Allergy Clin. Immunol. 114: 444-450. (Pubitemid 39119050)
32. 3 in primary human keratinocytes. J. Cell Biochem. 93: 951-967.
33. Yamasaki, K., J. Schauber, A. Coda, H. Lin, R. A. Dorschner, N. M. Schechter, C. Bonnart, P. Descargues, A. Hovnanian, and R. L. Gallo. 2006. Kallikreinmediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 20: 2068-2080. (Pubitemid 44953906)
34. Koga, C., K. Kabashima, N. Shiraishi, M. Kobayashi, and Y. Tokura. 2008. Possible pathogenic role of Th17 cells for atopic dermatitis. J. Invest. Dermatol. 128: 2625-2630.
35. Howell, M. D., R. L. Gallo, M. Boguniewicz, J. F. Jones, C. Wong, J. E. Streib, and D. Y. Leung. 2006. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24: 341-348.